Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine vs phenylephrine for inflammation and oxidative metabolism after cesarean section under spinal anesthesia
ChiCTR2400089827Phase 4Not yet recruiting
- Sponsor
- Hefei Second People's Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Maternal inflammatory response (MIR), fetal inflammatory response syndrome (FIRS) and oxidative stress comparing Norepinephrine group with Phenylephrine group (2 arms). Primary endpoint: Presepsin. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
norepinephrinephenylephrine
03
Conditions
Maternal inflammatory response (MIR)fetal inflammatory response syndrome (FIRS)oxidative stress
Beyond the preview
Go deeper on ChiCTR2400089827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089827.